Sandu Pharmaceuticals Q1 Results

  • BSE: 524703
  • NSE: -
  • ISIN: INE751D01014
  • Sector: Biotechnology & Drugs
BSE
57.820.02 (0.03%)
Volume1.30 K
Updated: Tue 26 Nov, 2024 | 15:21:03
NSE
This stock is not traded on NSE
Today: 57.00
59.15
52-Wk: 54.00
85.00

Q1 Results Highlights

  • Total Income
    ₹17.05 Cr.
    (9.28%)
  • Operating Profit
    ₹0.25 Cr.
    (-40.78%)
  • Profit After Tax
    ₹0.17 Cr.
    (-71.91%)
  • Operating Margin
    1.45%
    (9.66%)
Note: Comparison is on YoY basis

Quarterly - Sandu Pharmaceuticals Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
Total Revenue 17.0515.26-%17.66-%
Selling/ General/ Admin Expenses Total 2.333.07-%2.52-%
Depreciation/ Amortization 0.160.13-%0.12-%
Other Operating Expenses Total 5.015.49-%5.33-%
Total Operating Expense 16.8014.92-%17.42-%
Operating Income 0.250.35-%0.23-%
Net Income Before Taxes 0.270.38-%0.21-%
Net Income 0.170.27-%0.11-%
Diluted Normalized EPS 0.170.27-%0.11-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts